Todd Brady,Scott Young,William A. Kinney,Kenneth J. Mandell
申请号：
US16262364
公开号：
US10543181B2
申请日:
2019.01.30
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides for the treatment, prevention, and/or reduction of a risk of a disease, disorder, or condition in which aldehyde toxicity is implicated in the pathogenesis, including ocular disorders, skin disorders, conditions associated with injurious effects from blister agents, and autoimmune, inflammatory, neurological and cardiovascular diseases by the use of a primary amine to scavenge toxic aldehydes, such as MDA and HNE.
